ELI LILLY & Co
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
LLY$1,432.29+1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Balance Sheets
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Assets · (Unaudited) | ||
| Current Assets | ||
| Cash and cash equivalents (Note 6) | $2,460.2 | $2,818.6 |
| Short-term investments (Note 6) | 126.1 | 109.1 |
| Accounts receivable, net of allowances of $14.3 (2024) and $14.8 (2023) | 7,885.6 | 9,090.5 |
| Other receivables | 2,127.9 | 2,245.7 |
| Inventories (Note 5) | 6,101.8 | 5,772.8 |
| Prepaid expenses | 6,348.6 | 5,540.8 |
| Other current assets | 138.6 | 149.5 |
| Total current assets | 25,188.8 | 25,727.0 |
| Investments (Note 6) | 3,086.9 | 3,052.2 |
| Goodwill | 4,939.6 | 4,939.7 |
| Other intangibles, net | 6,762.2 | 6,906.6 |
| Deferred tax assets | 5,633.9 | 5,477.3 |
| Property and equipment, net of accumulated depreciation of $11,235.0 (2024) and $11,099.3 (2023) | 13,624.0 | 12,913.6 |
| Other noncurrent assets | 4,708.1 | 4,989.9 |
| Total assets | $63,943.5 | $64,006.3 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | $1,651.5 | $6,904.5 |
| Accounts payable | 2,473.7 | 2,598.8 |
| Employee compensation | 844.2 | 1,650.4 |
| Sales rebates and discounts | 9,429.6 | 11,689.0 |
| Dividends payable | — | 1,169.2 |
| Other current liabilities | 4,199.1 | 3,281.3 |
| Total current liabilities | 18,598.1 | 27,293.2 |
| Noncurrent Liabilities | ||
| Long-term debt | 24,559.9 | 18,320.8 |
| Accrued retirement benefits (Note 8) | 1,427.9 | 1,438.8 |
| Long-term income taxes payable | 4,189.4 | 3,849.2 |
| Other noncurrent liabilities | 2,270.8 | 2,240.6 |
| Total noncurrent liabilities | 32,448.0 | 25,849.4 |
| Commitments and Contingencies (Note 9) | ||
| Eli Lilly and Company Shareholders' Equity | ||
| Common stock | 594.2 | 593.6 |
| Additional paid-in capital | 7,009.5 | 7,250.4 |
| Retained earnings | 12,553.9 | 10,312.3 |
| Employee benefit trust | (3,013.2) | (3,013.2) |
| Accumulated other comprehensive loss (Note 10) | (4,299.5) | (4,327.0) |
| Cost of common stock in treasury | (32.7) | (44.2) |
| Total Eli Lilly and Company shareholders' equity | 12,812.2 | 10,771.9 |
| Noncontrolling interests | 85.2 | 91.8 |
| Total equity | 12,897.4 | 10,863.7 |
| Total liabilities and equity | $63,943.5 | $64,006.3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.